Healthcare -
Biotechnology - NASDAQ - US
$ 1.14
4.59 %
$ 150 M
Market Cap
-0.41
P/E
Price Target
Average
1704.51%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
49.12%
Net Income
Estimate
52.33%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
RAPT Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for RAPT of $20.6 , with forecasts ranging from
a
low of
$2 to a high of $55 .
RAPT Lowest Price Target
Wall Street Target
2 USD
75.44%
RAPT Average Price Target
Wall Street Target
20.6 USD
1704.51%
RAPT Highest Price Target
Wall Street Target
55 USD
4724.56%
REVENUE FORECAST
Revenue Forecast Chart RAPT
EBIT FORECAST
EBIT Forecast Chart RAPT
NET INCOME FORECAST
Net Income Chart RAPT